European Parliament and Commission clash over endocrine disruptors

Illustration: World Health Organization

MEPs reject the Commission’s proposal and join public health NGOs in demanding more rigorous protection.

What are endocrine disrupting chemicals (EDCs) and what do we know about their dangers?

In its policy communication on endocrine disruption, the European Commission defines an endocrine disruptor as “an exogenous substance or mixture that alters function(s) of the endocrine system and consequently causes adverse health effects in an intact organism, or its progeny, or (sub)populations”.

According to the World Health Organisation (WHO), EDCs “encompass a variety of chemical classes, including natural and synthetic hormones, plant constituents, pesticides, compounds used in the plastics industry and in consumer products, and other industrial by-products and pollutants. They are often pervasive and widely dispersed in the environment. Some are persistent, can be transported long distances across national boundaries, and have been found in virtually all regions of the world. Others are rapidly degraded in the environment or human body or may be present for only short periods of time but at critical periods of development.”

The Commission acknowledges that “EDCs have been suggested as being responsible for apparent changes seen in human health patterns over recent decades.” The Commission also lists some of the dangers associated with EDCs: declining sperm counts in some geographical regions, increased numbers of male children born with genital malformations and increases in the rates of certain types of cancer.

Nevertheless, since the effects of EDCs are not yet fully understood, the public debate around these toxins has become quite controversial.

The journalist Stéphane Horel co-directed and co-authored a documentary “The Great Invasion”, in which she demonstrates how exposed we are to EDCs and interviews several academics, such as Philippe Grandjean from Harvard University School of Public Health and Andreas Kortenkamp from Brunel University London, who warn of the potential perils of EDCs to human health and the environment.

Several studies supported by the US National Institutes of Health (1, 2, 3, 4) have come to the conclusion that EDCs may affect vital organs in humans, such as the hypothalamus, thyroid, pancreas and pituitary glands, which are responsible for development, metabolism, reproduction and even mood.

Nevertheless, these studies as well as other healthcare professionals urge for more research on the subject. “We urgently need to obtain a fuller picture of the health and environment impacts of EDCs,” said Maria Neira, the WHO’s director for public health and environment.

The Commission’s recent statement that the “potential mode of action of any such effect is unknown” seems to reveal, however, at least a worrying lack of necessary precaution, if not a disturbing inclination to embrace that “unknown” and do nothing, despite of the growing amount of biomedical literature on the subject.

The Commission’s proposal and the reactions of the Parliament

Under the EU’s biocides regulation (1107/2009), the Commission was obliged to define scientific criteria for defining potential EDCs by December 2013. In other words, the Commission was tasked with establishing a set of standards that would categorise EDCs and therefore expose their potential hazards.

However, the EU executive delayed the delivery of the criteria after deciding to make an impact assessment. In July 2014, Sweden, which swiftly took regulatory action on the matter at national level, sued the Commission and won the case.

In December 2015, the General Court of the EU decided that the Commission had breached EU law by failing to set criteria for EDCs. Finally, in June 2016, the Commission proposed that a substance should be considered an EDC only if it fulfills all of the following criteria: it is known to cause an adverse effect on human health; it has an endocrine mode of action; the adverse effect relevant for human health is a consequence of the endocrine mode of action (that is, if there is a causal link between adverse effect and mode of action).

On 4 July, a majority of EU member states accepted a draft law from the Commission in the Standing Committee on Plants, Animals and Feed (an official meeting where member states cast their votes on important issues mainly related with health and food safety).

Vytenis Andriukaitis, the EU Commissioner for Health and Food Safety, subsequently hailed the member states’ approval “a great success” and urged the European Parliament and the Council, involved in the decision-making process, to ensure the law’s smooth adoption.

The European Parliament and NGOs, however, were less welcoming toward this draft law, since its narrow scope – it only covered pesticides and biocides – would have left citizens vulnerable to many EDCs. On 28 September, the Parliament’s Environment and Public Health Committee objected to the Commission’s proposed criteria in a plenary session.

The [Commission’s] proposal is not all bad but it’s not good enough and above all, it is not legally sound,” said Jytte Guteland, the Swedish MEP (S&D Group), who filed the objection. The Parliament’s legal service found that the Commission had exceeded its mandate with the introduction of a derogation for so-called non-target organisms,” Guteland added, explaining her objection to the draft criteria.

The introduction of the derogation could create a loophole in the legislation allowing for some substances to be approved “for a limited period necessary to control serious danger to plant health”.

As a consequence, the MEPs Guteland and Bas Eickhout (The Greens) penned a Motion for a Resolution on the basis that the Commission’s draft regulation “could not be considered to be based on objective scientific data related to the endocrine system, as required by the [European] Court”, while also accusing the EU Executive of “exceeding its implementing powers” by “modifying an essential regulatory element of Regulation (EC) No 1107/2009”.

“It is unacceptable that the Commission tries to lift a ban of certain EDCs via the backdoor of comitology to further the interests of the pesticides industry. The Commission has a mandate to come up with scientific criteria for EDCs, but not to undo a ban decided by the legislator,” Eickhout stated on 3 October, a day before the final vote in the European Parliament, in Strasbourg.

The Motion objecting to the draft criteria, co-signed by the Socialists and the Greens, was adopted by 36 votes to 26. The Parliament has also blocked access to lobbyists from Monsanto, a US multinational agrochemical and agricultural biotechnology corporation, after it refused to participate in a public hearing.

Finally on the “D-Day” of 4 October, an absolute majority of 389 MEPs blocked the European Commission’s proposed criteria to identify EDCs.

MEPs and the Council “have already clearly decided to ban all EDCs. The Commission was only mandated to set scientific criteria to identify the endocrine-disrupting substances, nothing more. Instead, it decided to include a derogation for certain substances, thereby creating a huge loophole in the legislation,” Gutteland said to EUobserver.

Democracy and the precautionary principle – 1, lobbyists of the agrochemical industry – 0,” tweeted French MEP Eric Andrieu (S&D group) after the vote.

This is a very important message that the European Parliament is sending to the Commission. The European Parliament does not accept any kind of circumvention. It is utterly necessary to have scientific criteria for the determination of EDCs,” said MEP Notis Marias (ECR group) regarding the executive’s attempt to change Regulation 1107/2009. “We saw that many of the different criteria emerged from political agreements and had nothing to do with scientific documentation,” added Marias.

The conservative MEP said it is “quite clear” that EDCs are dangerous chemicals for public health and the environment and finished his statement by greeting the final vote and the “decisiveness of the Parliament concerning the message that lobbyists can’t do whatever they want”.

NGOs congratulate the Parliament

The not-for-profit organisation Health and Environment Alliance (HEAL) applauded “the courageous decision to veto a proposal that lacks ambition and would fail to protect human health and the environment” in a statement, in which it also claimed that “EDCs are hidden everywhere in our daily environment and evidence of their adverse effects – sometimes decades later and especially for children – is growing by the day”.

The European Consumer Organisation (BEUC) shared the sentiment stating that the Parliament had rightly said “no” to the Commission’s lack of ambition: “BEUC applauds the Parliament’s decision to reject this unfit definition because too many chemicals would escape the regulatory net.”

What comes next?

With the veto in Parliament, the Commission, now back at square one, must change the proposal together with the representatives of the member states in the Standing Committee and present it again to the Parliament and the Council.

The Parliament called on the EU executive to ensure that the guidance for the implementation of the hazard-based criteria to identify EDCs is in line with the scientific criteria to determine endocrine-disrupting properties.

Moreover, MEPs called on the Commission to ensure that the same guidance clarifies that there is no hierarchy that gives preference to scientific data generated in accordance with internationally agreed study protocols over other scientific data.

Once the criteria are formally adopted, the EU will boast the world’s first regulatory system to enshrine a definition of EDCs in law.

Marta Pacheco

Marta Pacheco studied Political Science and Media & Journalism at the Catholic University of Portugal (UCP). An independent researcher based in Brussels, she has been active in reporting EU and international affairs as a journalist contributor for media outlets in Brussels. Former Blue Book trainee in the European Commission and with a keen interest on politics and global affairs, Marta has been developing her skills and knowledge in the healthcare field, energy & environment and in the financial crisis.

Would you like to share your thoughts?

Your email address will not be published.

Legal note

1.    Terms and Conditions

2.    Privacy Policy

3.    Cookies Policy


1.    Terms and Conditions

Contact data for the web owner

This website has been created by KATOIKOS to promote their products and services.

– Name: Katoikos, S.L

– Co. tax Code:  B87123162

– Address:  Calle Campomanes 10, 28013  Madrid (SPAIN)

Registration details: Registered in the Commercial Register of Madrid.

Intellectual and Industrial Property

The various elements of this page, and website as a whole, are protected by Spanish legislation on intellectual and industrial property. The trademarks, trade names or logos appearing on this website are the property of the company, or, where appropriate, of third parties, and are protected by Trademarks Law, and of which KATOIKOS holds the legitimate license.

The information provided may not be used for commercial or public purposes, or modified. If the user downloads materials for personal and non-commercial use, warnings shall be kept about copyright and trademarks. To download and use the company logo that appears on the website, prior authorization is required.

Any unauthorised use of the images may violate copyright laws, trademark laws, the laws of privacy and publicity, and communications regulations and statutes.

Liability for Damage

KATOIKOS assumes no liability for damages you may suffer when browsing the web or in the use of computer applications that are part of it. Neither are warranties given as to the correction of malfunctions or updating of content.

Content you share with us

We may include features on this website that allow you to share your content with us and other users of the site. Please note that by sharing content it may become publicly accessible. You grant to Katoikos a worldwide, non-exclusive, transferable, royalty-free, perpetual, irrevocable right and license, without compensation to you:

 (a) to use, reproduce, distribute, adapt (including without limitation edit, modify, translate, and reformat), derive, transmit, display and perform, publicly or otherwise, such content, in any media now known or hereafter developed, for Kaotikos’ business purposes, and

 (b) to sublicense the foregoing rights, through multiple tiers, to the maximum extent permitted by applicable law. The foregoing licenses shall survive any termination of your use of the site, as further described below.

For all of the content you share through the site, you represent and warrant that you have all rights necessary for you to grant these licenses, and that such content, and your provision or creation thereof through the site, complies with all applicable laws, rules, and regulations and does not infringe or otherwise violate the copyright, trademark, trade secret, privacy or other intellectual property or other rights of any third party, and is furthermore free from viruses and other malware.

Rules of Conduct

When using this website and/or sharing content with us, you are prohibited from posting or transmitting :

1. any unlawful, threatening, defamatory, racist, obscene, scandalous, deceptive, false, fraudulent, inflammatory or profane material or any material that could constitute or encourage conduct that would be considered a criminal offence, give rise to civil liability, or otherwise violate any law.
2. Any virus, worm, Trojan horse, Easter egg, time bomb, spyware or other computer code, file, or program that is harmful or invasive or may or is intended to damage or hijack the operation of, or to monitor the use of, any hardware, software or equipment;
3. Any unsolicited or unauthorized advertising, promotional materials, “junk mail,” “spam,” “chain letter,” “pyramid scheme” or investment opportunity, or any other form of solicitation; and
4. Any material non-public information about a person or a company without the proper authorization to do so.

In addition, you will not:

1. Use this website for any fraudulent or unlawful purpose;
2. Interfere with or disrupt the operation of the website or the servers or networks used to make the website available; or violate any requirements, procedures, policies or regulations of such networks;
3. Access or use this website through any technology or means other than those expressly designated by us.
4. Restrict or inhibit any other person from using this website (including by hacking or defacing any portion of the website);
5. Except as expressly permitted by applicable law, modify, adapt, translate, reverse engineer, decompile or disassemble any portion of this website.
6. Remove any copyright, trademark or other proprietary rights notice from this website.
7. Frame or mirror any part of the webiste without our express prior written consent;
8. Create a database by systematically downloading and storing all or any content;
9. Use any robot, spider, site search/retrieval application or other manual or automatic device to retrieve, index, “scrape,” “data mine” or in any way reproduce or circumvent the navigational structure or presentation of this website, without our express prior written consent.


Kaotikos  reserves the right to remove any messages or statements or cancel any links.

This site may include hyperlinks to other web sites that are not owned or controlled by Katoikos. Katoikos has no control over, and assumes no responsibility for, the content, privacy policies, security or practices of any third party websites.

Content may be hosted on YouTube or other social media. Those operate their own set of terms and conditions and privacy policy which are separate to the ones presented on this website. Katoikos no control over and assumes no responsibility for, the content, privacy policies, security or practices on YouTube or other social media.

 The right to terminate your access

Katoikos reserves the right to terminate your access to this website at any time if you do not comply with these Terms and Conditions or you infringe Kaotikos’ rights in the content provided on this website.

Governing Law

These Terms and Conditions are governed by and construed in accordance with the laws of Spain, without regard to its choice of law provisions.  You agree to the exclusive jurisdiction by the courts of Spain.

Changes to the Terms

Katoikos reserves the right to make changes to the Terms and Conditions from time to time. You acknowledge and agree that your continued access to or use of this website will constitute your acceptance of such changes.

2.    Privacy Policy

Kaotikos takes the protection of your personal data very seriously and collects, processes and uses your data only in accordance with the standards of the legal data protection regulations.

Data is collected, processed and used with technologyes of the provider web trends for marketing and optimisation purposes and also for sending news and information you may be interested in by any electronic services, such as email or SMS.

Our website user’s database is registered at the Spanish Agency of Data Protection. You have the rights of access, rectification, deletion and opposition, regulated in articles 14 to 16 of the LOPD.

For this, please write to:

KATOIKOS (Data Protection) Calle Campomanes 10, 28013, Madrid (SPAIN)

Or send an email to Your ID will be requested for these issues.

3.    Cookies Policy

This site, like many others, uses small files called cookies to help us customise your experience. Find out more about cookies and how you can control them.

This page contains information on what ‘cookies’ are, the cookies used by the Kaotikos’ website and how to switch cookies off in your browser.

If it does not provide the information you were looking for, or you have any further questions about the use of cookies on the Katoikos’s website, please email

What are ‘cookies’?

‘Cookies’ are small text files that are stored by the browser (for example, Internet Explorer or Safari) on your computer or mobile phone. They allow websites to store things like user preferences. You can think of cookies as providing a ‘memory’ for the website, so that it can recognise you when you come back and respond appropriately.

How does the Katoikos’s website use cookies?

A visit to a page on the Kaotikos’s website may generate the following type of cookies: Anonymous analytics cookies.

This website uses Google Analytics, a web analytics service provided by Google, Inc., a Delaware company whose main office is at 1600 Amphitheatre Parkway, Mountain View (California), CA 94043, USA (“Google”).

Google Analytics uses “cookies”, which are text files placed on your computer, to help the website analyze how users use the site. The information generated by the cookie about your use of the website (including your IP address) will be transmitted to and stored by Google on servers in the United States. Google will use this information on our behalf in order to track your use of the website, compiling reports on website activity and providing other services relating to website activity and internet usage. Google may also transfer this information to third parties where required to do so by law, or where such third parties process the information on Google’s behalf. Google will not associate your IP address with any other data held by Google.

Anonymous analytics cookies

Cookier Name Origin Aim End
__utma Google Analysis 2 years since set –up or update
__utmb Google Analysis 30 minutes since set –up or update
__utmc Google Analysis When browser sesión ends
_utmt Google Analysis 10 minutes since set –up or update
__utmz Google Analysis 6 months since set –up or update

How do I turn cookies off?

It is usually possible to stop your browser accepting cookies, or to stop it accepting cookies from a particular website. All modern browsers allow you to change your cookie settings. You can usually find these settings in the ‘options’ or ‘preferences’ menu of your browser. To understand these settings, the following links may be helpful, or you can use the ‘Help’ option in your browser for more details.

Cookie settings in Internet Explorer
Cookie settings in Firefox
Cookie settings in Chrome
Cookie settings in Safari web and iOS.


© 2020 Katoikos, all rights are reserved. Developed by eMutation | New Media

Become a
Being up to date with Europe only takes a few seconds.
Your information will never shared with a third party.
Get our periodical newsletter sent to your inbox!
I have read and agreed the Privacy Policy (required)
Become a
Being up to date with Europe only takes a few seconds.
Get our periodical newsletter sent to your inbox!
Your information will never shared with a third party.
I have read and agreed the Privacy Policy (required)